Next-Generation Ocular Delivery Systems and Methods

A next-generation ocular delivery system that leverages micro-robotics, gene-editing, nanofluidics, machine learning, and bio-absorbable materials to revolutionize glaucoma treatment and ocular therapy.

The original patent disclosed systems and methods for accessing Schlemm's canal and delivering a fluid composition to treat glaucoma. However, these systems have limitations in terms of precision, efficacy, and patient comfort. The new inventive concept addresses these limitations by introducing cutting-edge technologies to create a more targeted, efficient, and personalized approach to ocular treatment.

The new inventive concept encompasses a range of innovative solutions, including micro-robotic devices for targeted trabeculotomy, gene-editing payloads for upregulating aqueous humor outflow pathways, nanofluidic chips for real-time aqueous humor flow rate manipulation, machine learning algorithms for personalized treatment parameter prediction, and bio-absorbable stents for permanently dilating Schlemm's canal. These solutions are designed to work together to create a comprehensive and adaptive ocular treatment system.

The new claims introduce a paradigm shift in ocular delivery systems and methods, moving beyond the original patent's viscoelastic fluid-based approach to incorporate micro-robotics, gene-editing, and nanofluidics. The inventive step lies in the integration of these disparate technologies to create a novel, highly effective, and personalized treatment platform.

Alternative embodiments may include the use of different types of micro-robotic devices, gene-editing payloads, or nanofluidic chip designs. Variations may also include the incorporation of additional sensors or feedback mechanisms to further enhance the system's adaptability and efficacy.

The next-generation ocular delivery system has significant commercial potential in the glaucoma treatment and ocular therapy markets, with potential applications in hospitals, clinics, and ambulatory surgical centers. The system's adaptability and personalized approach may also enable new business models, such as subscription-based services or pay-per-procedure models.